About Tempus AI
Tempus AI is a leading health technology company that leverages artificial intelligence (AI) and machine learning to advance precision medicine. Founded in 2015 by Eric Lefkofsky, the company was inspired by the need for more data-driven approaches in oncology care. Tempus has since built one of the world’s largest libraries of multimodal clinical and molecular data, coupled with an operating system (the Tempus Platform) designed to make this vast dataset accessible and actionable for healthcare providers and researchers.
For physicians, Tempus offers “Intelligent Diagnostics” that utilize AI, including generative AI, to enhance the accuracy, tailoring, and personalization of laboratory tests. Their AI-enabled physician platform, Hub, provides secure access to comprehensive patient insights, including guideline-matched therapies, information on treatment resistance, and opportunities for clinical trial enrollment. The platform also features “Patient Similarities” to identify comparable patient cases and “Consults” for secure peer-to-peer collaboration among clinicians. Tempus aims to optimize treatment decisions by matching a patient’s unique molecular profile with targeted therapies and rapidly identifying relevant clinical trials, thereby striving to deliver the right treatment to the right patient at the right time.
Beyond initial diagnostics, Tempus provides an automated “Active Follow-Up” service that delivers updated therapy recommendations as clinical guidelines evolve or new therapeutic options emerge, often without requiring a new patient sample. While initially focused on oncology, the company has expanded its reach to include other critical disease areas such as cardiology, neuropsychiatry (e.g., depression, anxiety, ADHD), infectious diseases, and radiology. Tempus also plays a significant role in drug discovery and development by offering de-identified clinical and molecular data and analytical tools to pharmaceutical and biotech companies, facilitating research and the development of next-generation therapeutics.
Focus Areas
Business Intelligence
| Key Investors | SoftBank Group, Baillie Gifford, New Enterprise Associates, Novo Holdings, Franklin Templeton Investments, T. Rowe Price, Revolution LLC, Google LLC, Lightbank, BlackRock Advisors LLC, JPMorgan Investment Management Inc., Vanguard Capital Management LLC |
| Partnerships | Moderna, Merck, SoftBank (joint venture SB Tempus in Japan), United Therapeutics, Recursion, CellCarta, Boehringer Ingelheim, GSK, Eisai, Bristol Myers Squibb, BioNTech |
| Acquisitions | Ambry Genetics (2024), Deep 6 AI (2025), Paige (2025), Personalis (2026) |
| Technology | Tempus has built an AI-enabled precision medicine platform powered by multimodal data, including over 9 million de-identified longitudinal records with linked clinical, molecular, and imaging modalities. Their platform includes clinical-grade foundation models like Virchow and PRISM for computational pathology, and oFM for multimodal oncology. They also utilize an agentic platform called Tempus Lens for oncology drug development, which helps assemble cohorts, simulate trials, and generate evidence. The company's approach emphasizes scalability, interdisciplinary collaboration, and integrating workflows directly into clinical systems. |
| FDA Clearances | 4 cleared products (estimated) |
What the Web Says
Tempus AI is a technology company focused on AI-enabled precision medicine, diagnostics, and data-driven healthcare innovation. While the company is praised for its mission-driven work and innovative use of AI in healthcare, employee reviews often highlight significant concerns regarding management, work-life balance, and compensation. Product reviews suggest that Tempus AI's tools are valuable for aggregating biomarkers and assisting in mutation-guided precision medicine, though some note that their assays have competitors and that AI is sometimes more of a 'punchline' than a core differentiator.
Overall: MixedStrengths
- Mission-driven work with real-world healthcare impact and improving patient outcomes through technology.
- Collaborative environment and smart coworkers.
- Opportunities to work on innovative technology at the intersection of AI and healthcare, including large-scale healthcare datasets and multimodal AI models.
- Strong revenue growth in genomics and data and services.
- Products are easy to use and helpful for tracking time and managing projects (referring to 'Tempus Resource' and 'Tempus' workforce management software).
- Helpful for aggregating biomarkers and research partnerships in oncology.
Limitations
- Poor work-life balance and employees often feel stretched thin.
- Management is frequently criticized for being disorganized, lacking transparency, having poor communication, and exhibiting toxic tendencies.
- Pay is not always market value, and there is negligible upward mobility and tiny salary increases.
- No 401K matching.
- Promotions are sometimes based on tenure rather than merit.
- Some Reddit discussions express skepticism about the company's profitability and the actual implementation of AI beyond a marketing term.
Based on reviews from: Indeed.com, Built In, AIToolsBox, Reddit, GuruFocus, Capterra, G2
Last updated: 2026-07-19
Videos
News, demos, and interviews about Tempus AI.
Videos load interactively. If none appear, search YouTube for Tempus AI →
Press & Coverage
Frequently Asked Questions
Investors
Who's funded Tempus AI.
Comparisons
When considering AI tools for clinical practice, physicians can choose between broad deterioration prediction and specialized diagnostic analysis. AgileMD’s eCARTv5 Clinical Deterioration Suite excels at continuous, real-time assessment of hospitalized adult patients, predicting the risk of death or ICU transfer hours in advance. It integrates directly with EHRs, leveraging up to 97 variables to provide […]
Related Companies
Google DeepMind is a leading artificial intelligence (AI) research laboratory, a subsidiary of Alphabet Inc., dedicated to developing advanced AI systems to benefit humanity. The company focuses on creating general-purpose AI that can learn and solve complex problems, drawing inspiration from neuroscience and machine learning. Their work spans various fields, including healthcare, scientific discovery, and […]
TalkToMedi is a Canadian healthcare AI company that has developed a clinical-grade voice AI platform called MEDI. This platform is designed to automate patient communication and administrative tasks for medical clinics, including family medicine, specialty clinics, allied health, and physiotherapy. MEDI handles high-volume patient calls, automating appointment inquiries, booking, rescheduling, and cancellations based on the […]
Menaela is an AI-first practice management system designed for solo practitioners, small private clinics, and clinic owners. It integrates patient communication, scheduling, CRM, and medical documentation into a single platform, aiming to replace multiple disconnected tools and bots. The system features an AI practice manager that understands natural-language requests, utilizes real clinic data, and performs […]
Avie is operated by AVIE TECNOLOGIA LTDA, headquartered in Santo André, São Paulo, Brazil. Avie provides WhatsApp reception in Brazilian Portuguese, appointment scheduling, rescheduling and cancellations through Google Calendar or Feegow, clinic CRM, follow-up messages and an online booking website. Clinic staff can review conversations and take over when human support is needed. Clinic CRM […]
Saile is a physician-founded healthcare technology company that addresses critical inefficiencies in healthcare staffing and credentialing. Their AI-powered platform acts as a “universal credential passport” for physicians, centralizing and managing all medical licenses, certifications, and CME credits in one secure, portable vault. This system aims to significantly reduce the administrative burden and delays associated with […]
Data Capture Experts (DCE) is an Australian-based healthcare AI company that is at the forefront of digital health transformation. They specialize in developing and implementing digital health platforms that integrate data, technology, and human-centered design to create intuitive and connected healthcare systems. Their flagship platform, DC2Vue, is designed to go beyond traditional Electronic Medical Records […]